170 related articles for article (PubMed ID: 20150437)
1. Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer.
Stella Tsai CS; Chen HC; Tung JN; Tsou SS; Tsao TY; Liao CF; Chen YC; Yeh CY; Yeh KT; Jiang MC
Am J Pathol; 2010 Apr; 176(4):1619-28. PubMed ID: 20150437
[TBL] [Abstract][Full Text] [Related]
2. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
3. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.
Tai CJ; Su TC; Jiang MC; Chen HC; Shen SC; Lee WR; Liao CF; Chen YC; Lin SH; Li LT; Shen KH; Yeh CM; Yeh KT; Lee CH; Shih HY; Chang CC
J Transl Med; 2013 Jan; 11():29. PubMed ID: 23369209
[TBL] [Abstract][Full Text] [Related]
4. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.
Jiang MC; Yeh CM; Tai CJ; Chen HC; Lin SH; Su TC; Shen SC; Lee WR; Liao CF; Li LT; Lee CH; Chen YC; Yeh KT; Chang CC
Am J Surg; 2013 Sep; 206(3):418-27. PubMed ID: 23806821
[TBL] [Abstract][Full Text] [Related]
5. Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer.
Tung MC; Tsai CS; Tung JN; Tsao TY; Chen HC; Yeh KT; Liao CF; Jiang MC
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1570-7. PubMed ID: 19383891
[TBL] [Abstract][Full Text] [Related]
6. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.
Lee WR; Shen SC; Shih YH; Chou CL; Tseng JT; Chin SY; Liu KH; Chen YC; Jiang MC
J Transl Med; 2015 Jun; 13():191. PubMed ID: 26070816
[TBL] [Abstract][Full Text] [Related]
7. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.
Tai CJ; Hsu CH; Shen SC; Lee WR; Jiang MC
J Exp Clin Cancer Res; 2010 Aug; 29(1):110. PubMed ID: 20701792
[TBL] [Abstract][Full Text] [Related]
8. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.
Yuksel UM; Dilek G; Dogan L; Gulcelik MA; Berberoglu U
Tumori; 2015; 101(2):194-8. PubMed ID: 25791533
[TBL] [Abstract][Full Text] [Related]
9. Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.
Jiang K; Neill K; Cowden D; Klapman J; Eschrich S; Pimiento J; Malafa MP; Coppola D
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):552-556. PubMed ID: 27941559
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
[TBL] [Abstract][Full Text] [Related]
11. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
Liao CF; Lin SH; Chen HC; Tai CJ; Chang CC; Li LT; Yeh CM; Yeh KT; Chen YC; Hsu TH; Shen SC; Lee WR; Chiou JF; Luo SF; Jiang MC
Mol Med; 2012 Dec; 18(1):1269-80. PubMed ID: 22952058
[TBL] [Abstract][Full Text] [Related]
12. Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?
Yuksel UM; Turker I; Dilek G; Dogan L; Gulcelik MA; Oksuzoglu B
Oncol Res Treat; 2015; 38(9):431-4. PubMed ID: 26278417
[TBL] [Abstract][Full Text] [Related]
13. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.
Liao CF; Luo SF; Li LT; Lin CY; Chen YC; Jiang MC
J Exp Clin Cancer Res; 2008 Jul; 27(1):15. PubMed ID: 18597698
[TBL] [Abstract][Full Text] [Related]
14. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.
Ma S; Yang D; Liu Y; Wang Y; Lin T; Li Y; Yang S; Zhang W; Zhang R
Aging (Albany NY); 2018 Aug; 10(8):2062-2078. PubMed ID: 30144787
[TBL] [Abstract][Full Text] [Related]
15. Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium.
Uen WC; Tai CJ; Shen SC; Lee WR; Tsao TY; Deng WP; Chiou HY; Hsu CH; Hsieh CI; Liao CF; Jiang MC
J Mol Histol; 2010 Oct; 41(4-5):259-66. PubMed ID: 20734115
[TBL] [Abstract][Full Text] [Related]
16. Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.
Zhu JH; Hong DF; Song YM; Sun LF; Wang ZF; Wang JW
Asian Pac J Cancer Prev; 2013; 14(2):1017-21. PubMed ID: 23621178
[TBL] [Abstract][Full Text] [Related]
17. Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon.
Tsao TY; Tsai CS; Tung JN; Chen SL; Yue CH; Liao CF; Wang CC; Jiang MC
Mol Cell Biochem; 2009 Jul; 327(1-2):163-70. PubMed ID: 19224336
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
19. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
Jiang MC
Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
[TBL] [Abstract][Full Text] [Related]
20. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF
FASEB J; 2012 Jun; 26(6):2446-56. PubMed ID: 22389439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
